Antiparkinsonian and behavioral effects of inactivation of the substantia nigra pars reticulata in hemiparkinsonian primates

Experimental Neurology

Volumn 167, Issue 2, 2001, Pages 410-424

  Wichmann, Thomas ^a   Kliem, Michele A ^a   DeLong, Mahlon R ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

Globus pallidus; Ibotenic acid; Lesion; MPTP; Muscimol; Parkinson's disease; Primate; Substantia nigra pars reticulata; Subthalamic nucleus

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; ANTIPARKINSON AGENT; IBOTENIC ACID; MUSCIMOL;

AKINESIA; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRADYKINESIA; BRAIN MAPPING; CONTROLLED STUDY; HISTOPATHOLOGY; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; RETICULAR FORMATION; RHESUS MONKEY; SUBSTANTIA NIGRA;

EID: 0035132955     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2000.7572     Document Type: Article

References (88)

1. The functional anatomy of basal ganglia disorders
2. Basal ganglia-thalamocortical circuits: Parallel substrates for motor, oculomotor, 'prefrontal' and 'limbic' functions
3. Parallel organization of functionally segregated circuits linking basal ganglia and cortex
4. Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate
5. Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
6. Treatment of advanced Parkinson's disease by GPi pallidotomy: 1 year pilot-study results
7. The organization of the efferent projections of the substantia nigra in the rat: A retrograde fluorescent double labeling study
8. Amelioration of Parkinsonian symptoms by inactivation of the subthalamic nucleus (STN) in MPTP treated green monkeys
9. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus
10. Role of the cat substantia nigra pars reticulata in eye and head movements. II. Effects of local pharmacological injections
11. Enhanced muscimol-induced behavioral responses after 6-OHDA lesions: Relevance to susceptibility for self-mutilation behavior in neonatally lesioned rats
12. Saccadic eye movement deficits in the MPTP monkey model of Parkinson's disease
13. Movement disorders induced by gamma-aminobutyric agonist and antagonist injections into the internal globus pallidus and substantia nigra pars reticulata of the monkey
14. A primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
15. Nigrothalamic projections in the monkey demonstrated by autoradiographic technics
16. Effect of unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway on GABA(A) receptor subunit gene expression in the rodent basal ganglia and thalamus
17. Depression and Parkinson's disease: A review
18. Frontal-subcortical circuits and human behavior
19. Behavioral alterations and loss of caudate modulation in the centrum medianum - Parafascicular complex of the cat following electrolytic lesions of the substantia nigra
20. Primate models of movement disorders of basal ganglia origin
21. Relations between movement and single cell discharge in the substantia nigra of the behaving monkey
22. Stereotactic ventral pallidotomy for Parkinson's disease
23. Verteilung von noradrenalin und dopamin (3-hydroxytyramin) im gehirn des menschen und ihr verhalten bei erkrankungen des extrapyramidalen systems
24. Functional recovery in parkinsonian monkeys treated with GDNF
25. Transsynaptic effect of an intrastriatal fetal nigral graft on the sensitivity of the substantia nigra pars reticulata to muscimol in the rat
26. Bilateral dorsolateral subthalamotomy for advanced Parkinson's disease
27. Bilateral subthalamic nucleotomy can be accomplished safely
28. Subthalamotomy improves MPTP-induced parkinsonism in monkeys
29. Involvement of basal ganglia transmitter systems in movement initiation
30. Organization of striatopallidal, striatonigral and nigrostriatal projections in the macaque
31. Visual and oculomotor functions of monkey substantia nigra pars reticulata. IV. Relation of substantia nigra to superior colliculus
32. Modification of saccadic eye movements by GABA-related substances. II. Effects of muscimol in monkey substantia nigra pars reticulata
33. Multiple output channels in the basal ganglia
34. Saccade responses to dopamine in human MPTP-treated parkinsonism
35. Organization of the nigrothalamocortical system in the rhesus monkey
36. Anatomical distinctions between the two basal ganglia afferent territories in the primate motor thalamus
37. Immunohistochemical localization of neurochemicals
38. The pedunculopontine tegmental nucleus: Where the striatum meets the reticular formation
39. Eye movements in monkeys with local dopamine depletion in the caudate nucleus. I. Deficits in spontaneous saccades
40. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease
41. Neuronal discharge related to motor task performance in the primate substantia nigra pars reticulata
42. Eye movements in monkeys with local dopamine depletion in the caudate nucleus. II. Deficits in voluntary saccades
43. Rotation induced by intranigral injections of GABA agonists and antagonists: Zone-specific effects
44. Fine structure of nigral and pallidal afferents in the thalamus: An EM autoradiography in the cat
45. Pallidotomy for Parkinson's diesease
46. MPTP: The promise of a new neurotoxin
47. Role of the monkey substantia nigra pars reticulata in orienting behavior and visually triggered arm movements
48. Performance of visually triggered wrist movements task in monkey: An application of information theory to evaluate deficits following unilateral substantia nigra pars reticulata lesion
49. Effect of GPi pallidotomy on motor function in Parkinson's disease
50. Saccadic eye movements in Parkinson's disease. II. Remembered saccades - Towards a unified hypothesis?
51. Saccadic eye movements in Parkinson's disease: I. Delayed saccades
52. Primate striatonigral projections: A comparison of the sensorimotor-related striatum and the ventral striatum
53. Activity in monkey substantial nigra neurons related to a simple learned movement
54. Thalamic input to mesial and superior area 6 in the macaque monkey
55. New concepts about the organization of basal ganglia output
56. Immunochemical analysis of dopamine transporter protein in Parkinson's disease
57. The afferent and efferent connections of the feline nucleus tegmenti pedunculopontinus, pars compacta
58. Activity of neurons in the region of the substantia nigra during feeding in the monkey
59. An autoradiographic study of cortical projections from motor thalamic nuclei in the macaque monkey
60. Topographic distribution and collateral projections of the two major populations of nigrothalamic neurons: A retrograde labeling study in the rat
61. GABA(A) and GABA(B) antagonists differentially affect the firing pattern of substantia nigra dopaminergic neurons in vivo
62. Local cerebral glucose utilization in monkeys with hemiparkinsonism induced by intracarotid infusion of the neurotoxin MPTP
63. The output organization of the substantia nigra in primate as revealed by a retrograde double labeling method
64. The primate motor thalamus
65. Functional activity of zona incerta neurons is altered after nigrostriatal denervation in hemiparkinsonian rats
66. Chronic flurazepam differentially regulates a behavioral effect of GABA agonists
67. Subcortical projections to the centromedian and parafascicular thalamic nuclei in the cat
68. Efferent conncetions of the centromedian and parafascicular thalamic nuclei in the squirrell monkey: A light and electron microscopic study of the thalamostriatal projection in relation to striatal heterogeneity
69. Activity of pars reticulata neurons of monkey substantia nigra in relation to motor, sensory, and complex events
70. Topographic intermingling of striatonigral and striatopallidal neurons in the rhesus monkey
71. Oculomotor abnormalities in Parkinson's disease
72. Differential synaptic innervation of striatofugal neurons projecting to the internal or external segments of the globus pallidus by thalamic afferents in the squirrel monkey
73. Role of the subthalamic nucleus in the regulation of nigral dopamine neuron activity
74. Intranigral transplantation of fetal substantia nigra allograft in the hemiparkinsonian rhesus monkey
75. Ultrastructural study of cholinergic and noncholinergic neurons in the pars compacta of the rat pedunculopontine tegmental nucleus
76. Polymer-encapsulated PC-12 cells demonstrate high-affinity uptake of dopamine in vitro and 18F-Dopa uptake and metabolism after intracerebral implantation in nonhuman primates
77. The efferent projections of the putamen in the monkey
78. Saccades and antisaccades in parkinsonian syndromes
79. Ocular motor deficits in Parkinson's disease. II. Control of the saccadic and smooth pursuit systems
80. Local inactivation of the sensorimotor territories of the internal segment of the globus pallidus and the subthalamic nucleus alleviates parkinsonian motor signs in MPTP treated monkeys
81. The primate subthalamic nucleus. III. Changes in motor behavior and neuronal activity in the internal pallidum induced by subthalamic inactivation in the MPTP model of parkinsonism
82. Comparison of MPTP-induced changes in spontaneous neuronal discharge in the internal pallidal segment and in the substantia nigra pars reticulata in primates
83. Functional and pathophysiological models of the basal ganglia
84. Models of basal ganglia function and pathophysiology of movement disorders
85. Demonstration of axon collateral projections from the substantia nigra pars reticulata to the superior colliculus and the parvicellular reticular formation in the rat